Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 60,800
-1,200 (-1.94%)
Feb 25, 2026, 3:30 PM KST
58.75% (1Y)
| Market Cap | 3.09T +48.0% |
| Revenue (ttm) | 154.05B +14.8% |
| Net Income | 2.31B |
| EPS | 45.51 |
| Shares Out | 50.78M |
| PE Ratio | 1,336.36 |
| Forward PE | 389.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 392,094 |
| Average Volume | 516,811 |
| Open | 61,600 |
| Previous Close | 62,000 |
| Day's Range | 60,600 - 64,000 |
| 52-Week Range | 24,000 - 63,500 |
| Beta | 0.84 |
| RSI | 64.59 |
| Earnings Date | Mar 6, 2026 |